Chronic infection with human immunodeficiency virus (HIV) can cause progressive loss of immune cell function, or exhaustion, which impairs control of virus replication. However, little is known about the development and maintenance, as well as heterogeneity of immune cell exhaustion. Here, we investigated the effects of HIV infection on immune cell exhaustion at the transcriptomic level by analyzing single-cell RNA sequencing of peripheral blood mononuclear cells from two healthy subjects (15,121 cells) and six HIV-infected donors (28,610 cells). We identified nine immune cell clusters and eight T cell subclusters according to their unique gene expression programs; three of these (exhausted CD4 + and CD8 + T cells and interferonresponsive CD8 + T cells) were detected only in samples from HIV-infected donors. An inhibitory receptor KLRG1 was identified in the exhausted T cell populations and further characterized in HIV infected individuals. We identified a novel HIV-1 specific exhausted CD8 + T cell population expressing KLRG1, TIGIT, and T-bet dim Eomes hi markers. Ex-vivo antibody blockade of KLRG1 restored the function of HIV-specific exhausted CD8 + T cells demonstrating the contribution of KLRG1 + population to T cell exhaustion and providing a novel target for developing immunotherapy to treat HIV chronic infection. Analysis of gene signatures also revealed impairment of B cell and NK cell function in HIVinfected donors. These data provide a comprehensive analysis of gene signatures associated with immune cell exhaustion during HIV infection, which could be useful in understanding exhaustion mechanisms and developing new cure therapies. We thank Drs. Doug Richman, Mario Stevenson, and Jon Karn for helpful discussions, Kristen Jepsen at the IGM Genomics Center for help with scRNA-seq, Celsa Spina of UCSD CFAR for flow analysis and members of the Rana lab for helpful discussions and advice. We also thank Dr. Song Chen for advice and help in sample preparation and data analysis.
The development of potent combination antiretroviral therapy (cART) has allowed HIV viremia to be controlled and significantly reduced the mortality of HIV-infected individuals; however, withdrawal of treatment leads to a rapid rebound of 2 viremia, indicating that the host immune system remains unable to control viral replication 1, 2 . HIVinduced dysfunction of the host immune system is one of the major causes of this recrudescence.
Persistent exposure to viral antigens leads to chronic activation of immune cells, progressive loss of function, and ultimately, to a state of exhaustion accompanied by complete loss of effector function [3] [4] [5] [6] . For example, exhausted CD8 + T cells lose their cytotoxic effector function and the ability to eradicate HIV-infected cells 7 . In addition, CD8 + T cell exhaustion prevents the differentiation of effector cells into memory cells with the ability to undergo rapid reactivation upon encounter with antigen 7, 8 . Chronically activated CD4 + T cells also lose their effector functions, including the production of cytokines, such as IL-2 and IL-21, that sustain HIV-specific CD8 + T cells [9] [10] [11] .
Consequently, HIV-induced CD4 + T cell depletion and exhaustion also results in dysfunction of HIVspecific CD8 + T cells, resulting in disease progression 7, 8 . Therefore, understanding the mechanisms by which HIV infection leads to immune exhaustion is critical for the development of vaccines and therapies for HIV and, possibly, for other viral infections.
Sustained expression of high levels of inhibitory receptors such as PD-1, CTLA-4, CD160, TIGIT, and TIM-3 is a hallmark of T cell exhaustion.
In HIV-infected individuals, expression of multiple inhibitory receptors has been demonstrated to correlate positively with plasma viral load and disease progression 6, [12] [13] [14] [15] . Notably, neutralizing antibody-mediated blockade of these receptors reverses T cell exhaustion by increasing the production of effector molecules and the proliferation of HIV-specific CD4 + and CD8 + T cells 6, [12] [13] [14] [15] .
Blockade of PD-1 in simian immunodeficiency virus (SIV)-infected macaques results in expansion of SIV-specific CD8 + T cells, proliferation of memory B cells, decreased viremia, and prolonged survival 16, 17 . Similarly, treatment with a PD-L1-blocking antibody suppresses viremia and increases CD4 + T cell counts in chronically HIV-infected humanized mice 18 . Intriguingly, a recent report described that nivolumab (anti-PD-1) treatment of an HIV-infected patient with non-smallcell lung cancer restored the function of HIVspecific CD8 + T cells and decreased the HIV reservoir 19 . A clinical trial is currently ongoing to evaluate the safety and efficacy of PD-1 blockade in HIV-infected individuals with a low CD4 + T cell count (NCT03367754).
Despite the great promise of reversal of T cell exhaustion as a curative strategy for HIV, little is known about the mechanisms involved in immune cell exhaustion in HIV-infected individuals at the transcriptomic level. In addition, chronic HIV infection is associated with exhaustion not only of T cells but also of B and NK cells [20] [21] [22] . Therefore, it is possible that these three exhausted cell populations could cooperate in contributing to host immune system dysfunction, allowing unchecked HIV replication and disease progression.
Single-cell RNA sequencing (scRNA-seq) is a powerful technological advance to analyze the transcriptomic profiles of individual cells, thus enabling the heterogeneity of cells affecting biological processes to be analyzed 23 . scRNA-seq can reveal cellular identity as well as spatial organization and clonal distribution in complex heterogeneous immune populations 24, 25 
RESULTS and DISCUSSION

Atlas of PBMCs in Healthy and HIV-Infected
Donors
To examine the landscape of immune cell 15, 121 PBMCs. An overview of the approach is given in Figure 1A . and S1G). Importantly, the absolute CD4 + T cell counts in the clinical blood samples and the numbers estimated from the scRNA-seq analysis showed a strong correlation (R 2 =0.8963, Figure   1F ), indicating that the scRNA-seq datasets accurately reflect the cell clusters present in the original blood samples. Figure S2A ), which is consistent with a recently described CD4-Tpm cytotoxic cell cluster 35 
Identification of Novel Genes Associated with T Cell Exhaustion
Since little is known about the gene signatures of Tex cells in HIV-infected donors, we further characterized the CD8 + Tex subsets by comparing their gene expression patterns with those of their unexhausted counterparts, which are typically Tem cells ( Figure 2A and Table 1 ). From this analysis, we identified a total of 39 genes that were commonly altered in CD8-Tex cells from at least which has many crucial immune functions and mediates cell-cell interactions 44 , suggesting another mechanism that may contribute to the exhaustion phenotype. Interestingly, Tex cells showed altered expression of genes involved in cytoskeletal function (TMSB4X, PFN1, ACTG1, COTL1, ARPC1B), energy metabolism (CMC1), and vesicle transportation (TRAPPC1) ( Figure 2E ). 6 These pathways have also been associated with CD8 + T cell exhaustion during lymphocytic choriomeningitis virus infection 40 HIV infection in a reciprocal pattern 48 . T-bet dim Eomes hi bulk or HIV-specific CD8 + T cells showed poor functional characteristics 48 . Therefore, we further analyzed the percentages of T-bet dim Eomes hi population in KLRG1 + TIGIT + CD8 + T cells.
The result showed that the frequency was much higher in HIV-infected PBMCs (Low VL, 23.3%;
High VL, 23.3%) compared with that from healthy donors (HD, 6.0%) ( Figure 3C ). In addition, in both HIV infection is known to hyperactivate B cells but, paradoxically, it also suppresses the antibody response 55 . We found that PBMCs from HIV- Growing evidence supports a role for NK cells in the antiviral response to HIV-1 60 . NK cell cytokine secretion and cytotoxic functions are controlled by multiple activating and inhibitory receptors 61 . Of note, we found that HIV infection markedly altered the expression of several NK receptor genes ( Figure 3B ). Among the activating receptor genes, CD160, NCR3, and CD69 were down-regulated while SLAMF7, CD2, and CD84
were up-regulated. Conversely, the inhibitory receptor genes LILRB1, LAG3, and TIGIT were upregulated and KLRB1, LAIR2, and SIGLEC7 were down-regulated. In addition, we observed increased expression of BIRC3, TNF, and IFNG, which have been proposed to be NK cell activation markers 22 . Despite the beneficial roles of NK cells in antiviral responses, their function is known to be impaired by chronic HIV infection 60 . Consistent with this, we found a reduction in the expression of genes involved in cytokine signaling proteins (e.g., In addition, we also analyzed a published scRNAseq dataset (from 8381 PBMCs) from another healthy donor (10x Genomics).
scRNA-seq Library Construction
PBMCs from the seven donors were thawed, and dead cells were removed using magnetic beads (AMSBIO, CB002) to ensure cell viability >80%. 
scRNA-seq Mapping
The scRNA-seq dataset was mapped against the human hg19 reference genome using CellRanger 
Single-Cell Differential Gene Expression
Analysis
Secondary analysis on the raw counts generated Analysis of differentially expressed genes in these two cell types enabled identification of signature genes from the heatmap and feature plots of these subpopulations.
Pseudotime Analysis
Seurat data matrices were imported into monocle3 for pseudotime analysis 45, 46 . 
Integrated Analysis of PBMCs from Healthy and
HIV-Infected Donors
Using the Seurat integration pipeline 63 , the PBMC datasets from three donors with high HIV load and two healthy donors were combined by executing the following steps. Individual datasets were filtered, log-normalized, and scaled using the same strategies and parameters as above. After preprocessing the data and selecting genes, canonical correspondence analysis (CCA) analysis was performed to define the shared correlation space between the two healthy donor samples. Multi-CCA was performed on the three samples from high viral load donors. After non-overlapping subpopulations were identified, the CCA subspaces were aligned with dimensional reduction. Another round of clustering was then performed on the two Seurat objects. The two integrations were then combined using the same procedures as above. To detect conserved and differentially expressed genes markers across datasets, differential expression testing was performed on the integrated datasets from all five samples. By performing these two steps, further information was obtained about exhaustion markers, and dot plots were generated 11 to display conserved and differentially expressed gene markers.
Flow Cytometry
For phenotyping analysis of PBMC, cryopreserved 
KLRG1 Functional Assay
For KLRG1 functional analysis, cryopreserved 
